ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 137 filers reported holding ITEOS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 2.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $46,145 | +34.6% | 3,383 | +8.0% | 0.02% | +200.0% |
| Q4 2023 | $34,285 | +48.7% | 3,131 | +48.7% | 0.01% | +400.0% |
| Q3 2023 | $23,050 | +34.7% | 2,105 | +62.9% | 0.00% | 0.0% |
| Q2 2023 | $17,107 | -26.8% | 1,292 | -24.7% | 0.00% | 0.0% |
| Q1 2023 | $23,355 | -34.8% | 1,716 | -6.5% | 0.00% | -66.7% |
| Q4 2022 | $35,838 | +15.6% | 1,835 | +15.7% | 0.00% | +200.0% |
| Q3 2022 | $31,000 | – | 1,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |